Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
140 GBX | +1,82% | -3,45% | -23,29% |
Vakgebied
Aantal werknemers: 51
Verkoop per activiteit
GBP in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Biotechnology
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +107,51% |
Verkoop per regio
GBP in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United Kingdom
47,3
%
| 0 | 6,1 % | 1 | 47,3 % | +1.500,00% |
United States
32,6
%
| 1 | 81,2 % | 1 | 32,6 % | -16,60% |
Switzerland
10,0
%
| - | - | 0 | 10,0 % | - |
India
5,6
%
| - | - | 0 | 5,6 % | - |
Rest of Europe
4,5
%
| 0 | 6,6 % | 0 | 4,5 % | +42,11% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 49 | - |
Susan Lowther
DFI | Director of Finance/CFO | 65 | 01-01-19 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-07 |
David Gerring
PRN | Corporate Officer/Principal | - | - |
Fiona Lawrence
LAW | General Counsel | - | - |
Manjit Rahelu
PRN | Corporate Officer/Principal | - | 05-04-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Smith
BRD | Director/Board Member | 78 | - |
Christine Soden
BRD | Director/Board Member | 66 | 01-05-21 |
Andrew Richards
CHM | Chairman | 64 | - |
Susan Lowther
DFI | Director of Finance/CFO | 65 | 01-01-19 |
Sarah Howell
CEO | Chief Executive Officer | 49 | - |
Mohammad Fazeli
BRD | Director/Board Member | 59 | 01-09-17 |
Jeremy Morgan
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 30 626 986 | 14 837 000 ( 48,44 %) | 0 | 48,44 % |
Bedrijfsgegevens
Arecor Therapeutics Plc
Chesterford Research Park
CB10 1XL, Little Chesterford
+44 1223 426 060
http://www.arecor.comSector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,29% | 53,17 mln. | |
+9,30% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,15% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,68% | 27,18 mld. | |
-21,92% | 19,44 mld. | |
+14,62% | 13,83 mld. | |
+31,85% | 12,4 mld. | |
+4,47% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel Arecor Therapeutics plc - London S.E.
- Onderneming Arecor Therapeutics plc